This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Transplantation, Other  • Diabetes Mellitus  • Genetic Counseling/ Testing/ Therapy  • Immunologic Disorders  • Alert me on articles by topic

Tracy Hampton, PhD

JAMA. 2006;296:2785-2786.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

New York City—While an autoimmune disease of any type is a serious condition that is often difficult to treat, finding a cure for type 1 diabetes is particularly daunting because of the nature of the pancreas and its insulin-producing beta cells.

"The pancreas is pathetic at regeneration," said Douglas Melton, PhD, of the Harvard Stem Cell Institute at Harvard University, in Cambridge, Mass.

Researchers are searching for cell replacement therapies that could provide long-term insulin production and regulation in individuals with diabetes, who lack insulin-secreting beta cells. (Photo credit: Steve Gschmeissner/www.sciencesource.com)

Thus, finding a way to generate beta cells poses a difficult challenge for researchers. The promise and shortcomings of various options were discussed by Melton and others at the New York Stem Cell Foundation's recent Translational Stem Cell Research Conference.

THE PURSUIT OF BETA CELLS

Progress in type 1 diabetes research and care has been impressive over the . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

In Vivo Imaging of {beta}-Cell Mass in Rats Using 18F-FP-(+)-DTBZ: A Potential PET Ligand for Studying Diabetes Mellitus
Kung et al.
JNM 2008;49:1171-1176.
ABSTRACT | FULL TEXT  

Cellular Therapy for Type 1 Diabetes: Has the Time Come?
Skyler
JAMA 2007;297:1599-1600.
FULL TEXT